LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="López Laso, E"
  2. AU="Habib, Saman"

Search results

Result 1 - 10 of total 70

Search options

  1. Article ; Online: Pseudotumor cerebri in the paediatric population: clinical features, treatment and prognosis.

    Labella Álvarez, F / Fernández-Ramos, J A / Camino León, R / Ibarra de la Rosa, E / López Laso, E

    Neurologia

    2024  Volume 39, Issue 2, Page(s) 105–116

    Abstract: Introduction: Pseudotumor cerebri (PC) in prepubertal patients displays certain characteristics that differentiate it from its presentation at the postpubertal stage. The aim of this study is to describe the characteristics of paediatric patients ... ...

    Abstract Introduction: Pseudotumor cerebri (PC) in prepubertal patients displays certain characteristics that differentiate it from its presentation at the postpubertal stage. The aim of this study is to describe the characteristics of paediatric patients diagnosed with PC at our centre and to compare them according to their pubertal status.
    Patients and methods: We included patients aged between 1 and 18 years who were diagnosed with PC in a tertiary-level hospital between 2006 and 2019 and who met the updated diagnostic criteria for PC. They were classified according to body weight and pubertal status. Subsequently, we analysed results from lumbar punctures, neuroimaging studies, ophthalmological assessments, and treatments received during follow-up.
    Results: We included 28 patients, of whom 22 were of prepubertal age and 6 were of postpubertal age. The mean age (standard deviation) was 9.04 (2.86) years. Among the postpubertal patients, 83.3% were boys, 66.7% of whom presented overweight/obesity. In the group of prepubertal patients, 27% were boys, 31.8% of whom were overweight. The most frequent symptoms were headache (89.9%) and blurred vision (42.9%). All patients presented papilloedema, and 21.4% manifested sixth nerve palsy. Possible triggers were identified in 28.6% of cases. Nineteen percent of patients presented clinical recurrence, all of whom were prepubertal patients. Complete clinical resolution was achieved in 55.6% of patients.
    Conclusion: Prepubertal patients with PC show lower prevalence of obesity, higher prevalence of secondary aetiologies, and higher recurrence rates than postpubertal patients.
    MeSH term(s) Male ; Humans ; Child ; Infant ; Child, Preschool ; Adolescent ; Female ; Pseudotumor Cerebri/diagnosis ; Pseudotumor Cerebri/epidemiology ; Overweight/complications ; Retrospective Studies ; Prognosis ; Obesity/complications
    Language English
    Publishing date 2024-01-23
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 2654369-2
    ISSN 2173-5808 ; 2173-5808
    ISSN (online) 2173-5808
    ISSN 2173-5808
    DOI 10.1016/j.nrleng.2024.01.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pseudotumor cerebri in the paediatric population: clinical features, treatment and prognosis.

    Labella Álvarez, F / Fernández-Ramos, J A / Camino León, R / Ibarra de la Rosa, E / López Laso, E

    Neurologia

    2021  

    Abstract: Introduction: Pseudotumor cerebri (PC) in prepubertal patients displays certain characteristics that differentiate it from its presentation at the postpubertal stage. The aim of this study is to describe the characteristics of paediatric patients ... ...

    Title translation Síndrome de pseudotumor cerebri en la población pediátrica: características clínicas, tratamiento y pronóstico.
    Abstract Introduction: Pseudotumor cerebri (PC) in prepubertal patients displays certain characteristics that differentiate it from its presentation at the postpubertal stage. The aim of this study is to describe the characteristics of paediatric patients diagnosed with PC at our centre and to compare them according to their pubertal status.
    Patients and methods: We included patients aged between 1 and 18 years who were diagnosed with PC in a tertiary-level hospital between 2006 and 2019 and who met the updated diagnostic criteria for PC. They were classified according to body weight and pubertal status. Subsequently, we analysed results from lumbar punctures, neuroimaging studies, ophthalmological assessments, and treatments received during follow-up.
    Results: We included 28 patients, of whom 22 were of prepubertal age and 6 were of postpubertal age. The mean age (standard deviation) was 9.04 (2.86) years. Among the postpubertal patients, 83.3% were boys, 66.7% of whom presented overweight/obesity. In the group of prepubertal patients, 27% were boys, 31.8% of whom were overweight. The most frequent symptoms were headache (89.9%) and blurred vision (42.9%). All patients presented papilloedema, and 21.4% manifested sixth nerve palsy. Possible triggers were identified in 28.6% of cases. Nineteen percent of patients presented clinical recurrence, all of whom were prepubertal patients. Complete clinical resolution was achieved in 55.6% of patients.
    Conclusion: Prepubertal patients with PC show lower prevalence of obesity, higher prevalence of secondary aetiologies, and higher recurrence rates than postpubertal patients.
    Language Spanish
    Publishing date 2021-05-31
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 2654369-2
    ISSN 2173-5808 ; 2173-5808
    ISSN (online) 2173-5808
    ISSN 2173-5808
    DOI 10.1016/j.nrl.2021.04.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Microcefalia primaria hereditaria de tipo 5. No todo es virus del Zika.

    Gascon-Jimenez, F J / Gallardo-Hernandez, F L / Fernandez-Ramos, J A / Aguilar-Quintero, M / Camino-Leon, R / Lopez-Laso, E

    Revista de neurologia

    2018  Volume 66, Issue 3, Page(s) 101–102

    Title translation Hereditary primary microcephaly type 5. Not everything is Zika virus.
    MeSH term(s) Diagnosis, Differential ; Humans ; Infant, Newborn ; Male ; Microcephaly/diagnosis ; Zika Virus Infection/diagnosis
    Language Spanish
    Publishing date 2018-01-09
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 1468278-3
    ISSN 1576-6578 ; 0210-0010
    ISSN (online) 1576-6578
    ISSN 0210-0010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Neuropatia craneal multiple: descripcion de tres pacientes pediatricos.

    Sancho-Montero, N / Fernandez-Ramos, J A / Caballero-Rodriguez, C / Camino-Leon, R / Lopez-Laso, E

    Revista de neurologia

    2018  Volume 67, Issue 8, Page(s) 321–323

    Title translation Multiple cranial neuropathy: a case report of three paediatric patients.
    MeSH term(s) Child ; Cranial Nerve Diseases/diagnosis ; Female ; Humans ; Male
    Language Spanish
    Publishing date 2018-10-19
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 1468278-3
    ISSN 1576-6578 ; 0210-0010
    ISSN (online) 1576-6578
    ISSN 0210-0010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes.

    Fernández-Ramos, Joaquín A / De la Torre-Aguilar, María José / Quintáns, Beatriz / Pérez-Navero, Juan Luis / Beyer, Katrin / López-Laso, Eduardo

    Parkinsonism & related disorders

    2021  Volume 94, Page(s) 67–78

    Abstract: Introduction: In 2009, we described a possible founder effect of autosomal dominant Segawa disease in Córdoba (Spain) due to mutation c.265C>T (p. Q89*) in the GCH1 gene. We present a retrospective multicentre study aimed at improving our knowledge of ... ...

    Abstract Introduction: In 2009, we described a possible founder effect of autosomal dominant Segawa disease in Córdoba (Spain) due to mutation c.265C>T (p. Q89*) in the GCH1 gene. We present a retrospective multicentre study aimed at improving our knowledge of Segawa disease in Spain and providing a detailed phenotypic-genotypic description of patients.
    Methods: Clinical-genetic information were obtained from standardized questionnaires that were completed by the neurologists attending children and/or adults from 16 Spanish hospitals.
    Results: Eighty subjects belonging to 24 pedigrees had heterozygous mutations in GCH1. Seven genetic variants have been described only in our cohort of patients, 5 of which are novel mutations. Five families not previously described with p. Q89* were detected in Andalusia due to a possible founder effect. The median latency to diagnosis was 5 years (IQR 0-16). The most frequent signs and/or symptoms were lower limb dystonia (38/56, 67.8%, p = 0.008) and diurnal fluctuations (38/56, 67.8%, p = 0.008). Diurnal fluctuations were not present in the phenotypes other than dystonia. Fifty-three of 56 symptomatic patients were treated with a levodopa/decarboxylase inhibitor for (mean ± SD) 12.4 ± 8.12 years, with 81% at doses lower than 350 mg/day (≤5 mg/kg/d in children). Eleven of 53 (20%) patients had nonresponsive symptoms that affected daily life activities. Dyskinesias (4 subjects) were the most prominent adverse effects.
    Conclusion: This study identifies 5 novel mutations and supports the hypothesis of a founder effect of p. Q89* in Andalusia. New insights are provided for the phenotypes and long-term treatment responses, which may improve early recognition and therapeutic management.
    MeSH term(s) Dystonic Disorders/genetics ; GTP Cyclohydrolase/genetics ; Humans ; Levodopa/therapeutic use ; Retrospective Studies ; Spain ; Treatment Outcome
    Chemical Substances Levodopa (46627O600J) ; GTP Cyclohydrolase (EC 3.5.4.16)
    Language English
    Publishing date 2021-11-25
    Publishing country England
    Document type Journal Article ; Multicenter Study
    ZDB-ID 1311489-x
    ISSN 1873-5126 ; 1353-8020
    ISSN (online) 1873-5126
    ISSN 1353-8020
    DOI 10.1016/j.parkreldis.2021.11.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Clinical improvements after treatment with a low-valine and low-fat diet in a pediatric patient with enoyl-CoA hydratase, short chain 1 (ECHS1) deficiency.

    Pata, Silvia / Flores-Rojas, Katherine / Gil, Angel / López-Laso, Eduardo / Marti-Sánchez, Laura / Baide-Mairena, Heydi / Pérez-Dueñas, Belén / Gil-Campos, Mercedes

    Orphanet journal of rare diseases

    2022  Volume 17, Issue 1, Page(s) 340

    Abstract: Background: Enoyl-CoA hydratase short-chain 1 (ECHS1) is a key mitochondrial enzyme that is involved in valine catabolism and fatty acid beta-oxidation. Mutations in the ECHS1 gene lead to enzymatic deficiency, resulting in the accumulation of certain ... ...

    Abstract Background: Enoyl-CoA hydratase short-chain 1 (ECHS1) is a key mitochondrial enzyme that is involved in valine catabolism and fatty acid beta-oxidation. Mutations in the ECHS1 gene lead to enzymatic deficiency, resulting in the accumulation of certain intermediates from the valine catabolism pathway. This disrupts the pyruvate dehydrogenase complex and the mitochondrial respiratory chain, with consequent cellular damage. Patients present with a variable age of onset and a wide spectrum of clinical features. The Leigh syndrome phenotype is the most frequently reported form of the disease. Herein, we report a case of a male with ECHS1 deficiency who was diagnosed at 8 years of age. He presented severe dystonia, hyperlordosis, moderate to severe kyphoscoliosis, great difficulty in walking, and severe dysarthria. A valine-restricted and total fat-restricted diet was considered as a therapeutic option after the genetic diagnosis. An available formula that restricted branched-chain amino acids and especially restricted valine was used. We also restricted animal protein intake and provided a low-fat diet that was particularly low in dairy fat.
    Results: This protein- and fat-restricted diet was initiated with adequate tolerance and adherence. After three years, the patient noticed an improvement in dystonia, especially in walking. He currently requires minimal support to walk or stand. Therefore, he has enhanced his autonomy to go to school or establish a career for himself. His quality of life and motivation for treatment have greatly increased.
    Conclusions: There is still a substantial lack of knowledge about this rare disorder, especially knowledge about future effective treatments. However, early diagnosis and treatment with a valine- and fat-restricted diet, particularly dairy fat-restricted diet, appeared to limit disease progression in this patient with ECHS1 deficiency.
    MeSH term(s) Animals ; Diet, Fat-Restricted ; Dystonia ; Enoyl-CoA Hydratase/genetics ; Enoyl-CoA Hydratase/metabolism ; Humans ; Male ; Quality of Life ; Valine
    Chemical Substances Enoyl-CoA Hydratase (EC 4.2.1.17) ; Valine (HG18B9YRS7)
    Language English
    Publishing date 2022-09-05
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2225857-7
    ISSN 1750-1172 ; 1750-1172
    ISSN (online) 1750-1172
    ISSN 1750-1172
    DOI 10.1186/s13023-022-02468-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: First splicing variant in HECW2 with an autosomal recessive pattern of inheritance and associated with NDHSAL.

    Rodríguez-García, María Elena / Cotrina-Vinagre, Francisco Javier / Bellusci, Marcello / Hernández-Sánchez, Laura / de Aragón, Ana Martínez / López-Laso, Eduardo / Martín-Hernández, Elena / Martínez-Azorín, Francisco

    Human mutation

    2022  Volume 43, Issue 10, Page(s) 1361–1367

    Abstract: We report the clinical and genetic features of a Caucasian girl who presented a severe neurodevelopmental disorder with drug-resistant epilepsy, hypotonia, severe gastro-esophageal reflux and brain magnetic resonance imaging anomalies. WES uncovered a ... ...

    Abstract We report the clinical and genetic features of a Caucasian girl who presented a severe neurodevelopmental disorder with drug-resistant epilepsy, hypotonia, severe gastro-esophageal reflux and brain magnetic resonance imaging anomalies. WES uncovered a novel variant in homozygosis (g.197092814_197092824delinsC) in HECW2 gene that encodes the E3 ubiquitin-protein ligase HECW2. This protein induces ubiquitination and is implicated in the regulation of several important pathways involved in neurodevelopment and neurogenesis. Furthermore, de novo heterozygous missense variants in this gene have been associated with neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL). The homozygous variant of our patient disrupts the splice donor site of intron 22 and causes the elimination of exon 22 (r.3766_3917+1del) leading to an in-frame deletion of the protein (p.Leu1256_Trp1306del). Functional studies showed a twofold increase of its RNA expression, while the protein expression level was reduced by 60%, suggesting a partial loss-of-function mechanism of pathogenesis. Thus, this is the first patient with NDHSAL caused by an autosomal recessive splicing variant in HECW2.
    MeSH term(s) Brain Diseases ; Female ; Humans ; Muscle Hypotonia/genetics ; Neurodevelopmental Disorders/genetics ; RNA Splicing ; Seizures ; Ubiquitin-Protein Ligases/genetics ; Ubiquitination
    Chemical Substances HECW2 protein, human (EC 2.3.2.26) ; Ubiquitin-Protein Ligases (EC 2.3.2.27)
    Language English
    Publishing date 2022-07-01
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1126646-6
    ISSN 1098-1004 ; 1059-7794
    ISSN (online) 1098-1004
    ISSN 1059-7794
    DOI 10.1002/humu.24426
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Response to everolimus of a progressive plexiform neurofibroma in Neurofibromatosis type 1.

    Mateos, Maria Elena / López-Laso, Eduardo / Vicente, Josefina / Ortega, Rosa / Vázquez, Fernando / Pérez-Navero, Juan Luis

    Pediatrics international : official journal of the Japan Pediatric Society

    2020  Volume 62, Issue 7, Page(s) 857–859

    MeSH term(s) Antineoplastic Agents/therapeutic use ; Child ; Everolimus/therapeutic use ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Neurofibroma, Plexiform/complications ; Neurofibroma, Plexiform/drug therapy ; Neurofibromatosis 1/complications ; Neurofibromatosis 1/drug therapy ; TOR Serine-Threonine Kinases/metabolism ; Treatment Outcome
    Chemical Substances Antineoplastic Agents ; Everolimus (9HW64Q8G6G) ; TOR Serine-Threonine Kinases (EC 2.7.1.1)
    Language English
    Publishing date 2020-07-06
    Publishing country Australia
    Document type Case Reports ; Journal Article
    ZDB-ID 1470376-2
    ISSN 1442-200X ; 1328-8067
    ISSN (online) 1442-200X
    ISSN 1328-8067
    DOI 10.1111/ped.14183
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Mielopatía aguda: importancia del diagnóstico precoz.

    Priego Ruiz, María Pilar / López Laso, Eduardo / Muñoz Sánchez, Raquel / Pérez Navero, Juan L

    Anales de pediatria (Barcelona, Spain : 2003)

    2016  Volume 84, Issue 6, Page(s) 348–349

    Title translation Acute myelopathy: importance of early diagnosis.
    MeSH term(s) Acute Disease ; Early Diagnosis ; Humans ; Infant ; Magnetic Resonance Imaging ; Male ; Spinal Cord Diseases/diagnostic imaging
    Language Spanish
    Publishing date 2016-06
    Publishing country Spain
    Document type Case Reports ; Journal Article
    ISSN 1695-9531
    ISSN (online) 1695-9531
    DOI 10.1016/j.anpedi.2015.06.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The clinical and biochemical hallmarks generally associated with GLUT1DS may be caused by defects in genes other than SLC2A1.

    Sánchez-Lijarcio, Obdulia / Yubero, Delia / Leal, Fátima / Couce, María L / González Gutiérrez-Solana, Luis / López-Laso, Eduardo / García-Cazorla, Àngels / Pías-Peleteiro, Leticia / de Azua Brea, Begoña / Ibáñez-Micó, Salvador / Mateo-Martínez, Gonzalo / Troncoso-Schifferli, Monica / Witting-Enriquez, Scarlet / Ugarte, Magdalena / Artuch, Rafael / Pérez, Belén

    Clinical genetics

    2022  Volume 102, Issue 1, Page(s) 40–55

    Abstract: Glucose transporter 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder caused by haploinsufficiency of the GLUT1 glucose transporter (encoded by SLC2A1) leading to defective glucose transport across the blood-brain barrier. This work describes ... ...

    Abstract Glucose transporter 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder caused by haploinsufficiency of the GLUT1 glucose transporter (encoded by SLC2A1) leading to defective glucose transport across the blood-brain barrier. This work describes the genetic analysis of 56 patients with clinical or biochemical GLUT1DS hallmarks. 55.4% of these patients had a pathogenic variant of SLC2A1, and 23.2% had a variant in one of 13 different genes. No pathogenic variant was identified for the remaining patients. Expression analysis of SLC2A1 indicated a reduction in SLC2A1 mRNA in patients with pathogenic variants of this gene, as well as in one patient with a pathogenic variant in SLC9A6, and in three for whom no candidate variant was identified. Thus, the clinical and biochemical hallmarks generally associated with GLUT1DS may be caused by defects in genes other than SLC2A1.
    MeSH term(s) Carbohydrate Metabolism, Inborn Errors/genetics ; Genetic Testing ; Glucose Transporter Type 1/genetics ; Humans ; Monosaccharide Transport Proteins/deficiency ; Monosaccharide Transport Proteins/genetics
    Chemical Substances Glucose Transporter Type 1 ; Monosaccharide Transport Proteins ; SLC2A1 protein, human
    Language English
    Publishing date 2022-04-15
    Publishing country Denmark
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 221209-2
    ISSN 1399-0004 ; 0009-9163
    ISSN (online) 1399-0004
    ISSN 0009-9163
    DOI 10.1111/cge.14138
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top